High Intensity Focused Ultrasound (HIFU) Market · GlobeNewswire Inc. Dublin, Feb. 20, 2026 (GLOBE NEWSWIRE) -- The "Competitive Landscape of High Intensity Focused Ultrasound (HIFU) Market Recent ...
Hello, and welcome to InMed Pharmaceuticals, Inc. 2025 Annual General Meeting of Shareholders. I will now turn the call over to Eric Adams, CEO. Please go ahead. Thank you. Ladies and gentlemen, the ...
Hosted on MSN
InMed faces challenges from new US legislation
InMed Pharmaceuticals ( (INM)) has issued an announcement. On December 12, 2025, InMed Pharmaceuticals announced that the recently signed H.R. 5371 Act in the United States could materially negatively ...
Despite the potential impact of the Act on BayMedica's commercial operations, the new legislation does not affect InMed's pharmaceutical drug development programs, which operate within the traditional ...
Vancouver, British Columbia--(Newsfile Corp. - June 13, 2025) - InMed Pharmaceuticals Inc. (INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary ...
InMed Pharmaceuticals Inc (NASDAQ:INM) shares are trading higher by 22.6% to $6.05 during Tuesday’s session after the company announced that INM-901 reduced Alzheimer’s-related inflammation in a ...
If your social media algorithm is tapped into the latest non-surgical aesthetic treatments as much as ours is – you’ve probably come across High-Intensity Focused Ultrasound – better known as HIFU ...
InMed Pharmaceuticals (INM) has released an update. InMed Pharmaceuticals has made significant strides in its pharmaceutical programs, particularly with its Alzheimer’s treatment candidate, INM-901, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results